Skip to content

The Archive · A Source

BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn for ALS

BrainStorm Investor Relations May 2025 ir.brainstorm-cell.com/2025-05-19-BrainStorm-Receives-FDA-Clearance-to-Initiate-Phase-3b-Trial-of-NurOwn-R-for-ALS

Reports that cite this source

Israel

← Back to the sources archive